Drug Target Insights Explained

Drug Target Insights
Cover:	Drug_Target_Insights_cover.jpg
Editor:	Giulio Zuanetti (interim)
Discipline:	Pharmacology
Language:	English
Abbreviation:	Drug Target Insights
Publisher:	AboutScience Srl
History:	2006–Present
Openaccess:	Yes
Website:	https://journals.aboutscience.eu/index.php/dti/index
Link1:	https://journals.sagepub.com/home/dti
Link1-Name:	SAGE website
Oclc:	502638151
Lccn:	2007243676
Issn:	1177-3928

Drug Target Insights is a peer-reviewed open access academic journal focusing on drug treatment targets and clinical therapeutics. The journal was founded in 2006 by Monica Milani and is currently edited by Giulio Zuanetti. It was originally published by Libertas Academica, but SAGE Publications became the publisher in September 2016.^[1] In 2020, the journal was transferred to AboutScience Srl.

Indexing

The journal is abstracted and indexed in the following bibliographic databases:^[2]

• Academic Search Premier
• DOAJ
• EMBASE
• Emerging Sources Citation Index
• Web of Science
• Scopus

According to Scopus, it has a 2020 CiteScore of 4.6, ranking 11th out of 67th in the category 'General Pharmacology, Toxicology and Pharmaceutics'.^[3]

Notes and References

1. Web site: Libertas Academica Journals to be published by SAGE. 19 September 2016. https://web.archive.org/web/20170202105318/https://us.sagepub.com/en-us/nam/libertas-academica-journals. 2017-02-02. dead.
2. 1177-3928 . Drug Target Insight . 2021-11-07.
3. Web site: Source Details: Drug Target Insights. Scopus . 2021-11-07.